comparemela.com

Latest Breaking News On - Jeito capital - Page 22 : comparemela.com

EyeBiotech Raises $65M in Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

City ofUnited kingdomSarah milsomSam smartPaul stephensArtios pharmaMike rossDavid guyerAnthonyp adamisAndreas wallnoeferJonathan prennerKate binghamSrinivas akkarajuUk national institute of health researchSv health investorsClinical research network

NMD Pharma Raises €35M Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Sabine dandiguianThomas holm pedersenLundbeck foundationRoche venture fundNovo holdingsAarhus universityJeito capitalManaging partnerMyasthenia gravisChief executive officer

NMD Pharma Raises €35 Million in a new Financing

NMD Pharma Raises €35 Million in a new Financing - New investor Jeito Capital joins current NMD Pharma investors - Proceeds will be used to progress lead clinical programs

United statesFrance generalKostenloser wertpapierhandelSabine dandiguianSabine dandiguiantoRoel bulthuisNovo nordiskThomas holm pedersenLundbeck foundationNovo groupEuropean unionNovo nordisk foundationRoche venture fundNovo holdingsConsilium strategic communicationsAarhus university

NMD Pharma Raises €35 Million in a new Financing

NMD Pharma Raises €35 Million in a new Financing - New investor Jeito Capital joins current NMD Pharma investors - Proceeds will be used to progress lead.

United statesSabine dandiguianSabine dandiguiantoRoel bulthuisThomas holm pedersenEuropean unionLundbeck foundationRoche venture fundNovo holdingsAarhus universityConsilium strategic communicationsJeito capitalManaging partnerMyasthenia gravisHolm pedersenChief executive officer

NMD Pharma Raises €35 Million in a new Financing

NMD Pharma Raises €35 Million in a new Financing - New investor Jeito Capital joins current NMD Pharma investors - Proceeds will be used to progress lead.

Sabine dandiguianSabine dandiguiantoRoel bulthuisThomas holm pedersenLundbeck foundationRoche venture fundNovo holdingsConsilium strategic communicationsJeito capitalManaging partnerMyasthenia gravisHolm pedersenChief executive officerJane elliottAshley tappLindsey neville

vimarsana © 2020. All Rights Reserved.